Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × Celecoxib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 9 Breast Neoplasms 9 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Paranasal Sinus Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Breast Carcinoma In Situ 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stomatitis 1 Smoldering Multiple Myeloma 1 Smoking 1 Recurrence 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Precancerous Conditions 1

Interventions

vandetanib 7 Sorafenib 6 Magnetic Resonance Spectroscopy 6 lenvatinib 5 cabozantinib 5 Sunitinib 4 Iodine-131 4 selpercatinib 3 AZD 6244 3 trametinib 2 tipifarnib 2 durvalumab 2 dabrafenib 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Thyrotropin Alfa 2 Paclitaxel 2 Nivolumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Everolimus 2 Bortezomib 2 Axitinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 tremelimumab 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡